[Incidence, therapy and prevention of cytomegalovirus disease after bone marrow transplantation].
Schuler
U
U
Abteilung II, Eberhard-Karls-Universität Tübingen.
Ehninger
G
G
D000914:Antibodies, Viral / Q000032:analysis; D016026:Bone Marrow Transplantation / Q000276:immunology*; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000276:immunology* / Q000401:mortality; D015774:Ganciclovir / Q000627:therapeutic use; D006801:Humans; D007116:Immunization, Passive; D009894:Opportunistic Infections / Q000188:drug therapy / Q000276:immunology* / Q000401:mortality; D015996:Survival Rate
D000914:Antibodies, Viral; D015774:Ganciclovir
Inzidenz, Therapie und Prophylaxe der Zytomegalovirus-(CMV-)Erkrankung nach Knochenmarktransplantation.